Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds

作者: Oleksandr Grytsai , Oksana Valiashko , Manon Penco-Campillo , Maeva Dufies , Anais Hagege

DOI: 10.1016/J.BIOORG.2020.104271

关键词:

摘要: Abstract Two series of compounds carrying 3-amino-1,2,4-triazole scaffold were synthesized and evaluated for their anticancer activity against a panel cancer cell lines using XTT assay. The 1,2,4-triazole synthesis was revisited the first pyridyl derivatives. biological results revealed efficiency core that could not be replaced clear beneficial effect 3-bromophenylamino moiety in position 3 triazole both (compounds 2.6 4.6) on several tested. Moreover, our point out an antiangiogenic these compounds. Overall, 5-aryl-3-phenylamino-1,2,4-triazole structure has promising dual activity.

参考文章(33)
Chao Ma, Anhui Wu, Yongqi Wu, Xuhong Ren, Maosheng Cheng, Design and synthesis of N-aryl isothioureas as a novel class of gastric H(+) /K(+) -ATPase inhibitors. Archiv Der Pharmazie. ,vol. 346, pp. 891- 900 ,(2013) , 10.1002/ARDP.201300276
Jiao Ye, Meng-Wu Xiao, Xuan-Qing Xie, Shen-Yi Qiu, Ming-Chong Dai, Wan Li, Fang Shen, Ai-Xi Hu, Synthesis and Cytotoxicity in Vitro of N-Aryl-4-(tert-butyl)-5-(1H-1,2,4-triazol-1-yl)thiazol-2-amine Journal of The Chinese Chemical Society. ,vol. 62, pp. 627- 631 ,(2015) , 10.1002/JCCS.201400395
Cyril Ronco, Richard Foucault, Emilie Gillon, Pierre Bohn, Florian Nachon, Ludovic Jean, Pierre-Yves Renard, New huprine derivatives functionalized at position 9 as highly potent acetylcholinesterase inhibitors. ChemMedChem. ,vol. 6, pp. 876- 888 ,(2011) , 10.1002/CMDC.201000523
C. R. Rasmussen, F. J. Villani, Jr., L. E. Weaner, B. E. Reynolds, A. R. Hood, L. R. Hecker, S. O. Nortey, A. Hanslin, M. J. Costanzo, E. T. Powell, A. J. Molinari, Improved Procedures for the Preparation of Cycloalkyl-, Arylalkyl-, and Arylthioureas Synthesis. ,vol. 1988, pp. 456- 459 ,(1988) , 10.1055/S-1988-27605
Siavosh Mahboobi, Stefan Dove, Andreas Sellmer, Matthias Winkler, Emerich Eichhorn, Herwig Pongratz, Thomas Ciossek, Thomas Baer, Thomas Maier, Thomas Beckers, Design of chimeric histone deacetylase- and tyrosine kinase-inhibitors: a series of imatinib hybrides as potent inhibitors of wild-type and mutant BCR-ABL, PDGF-Rbeta, and histone deacetylases. Journal of Medicinal Chemistry. ,vol. 52, pp. 2265- 2279 ,(2009) , 10.1021/JM800988R
Cyril Ronco, Eugénie Carletti, Jacques-Philippe Colletier, Martin Weik, Florian Nachon, Ludovic Jean, Pierre-Yves Renard, Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography. ChemMedChem. ,vol. 7, pp. 400- 405 ,(2012) , 10.1002/CMDC.201100438
Paul Eastwood, Jacob González, Elena Gómez, Francisco Caturla, Nuria Aguilar, Marta Mir, Josep Aiguadé, Victor Matassa, Cristina Balagué, Adelina Orellana, María Domínguez, None, Indolin-2-one p38α inhibitors III: Bioisosteric amide replacement Bioorganic & Medicinal Chemistry Letters. ,vol. 21, pp. 6253- 6257 ,(2011) , 10.1016/J.BMCL.2011.09.006
Janine Gioanni, Jean-Louis Fischel, Jean-Claude Lambert, Francois Demard, Christiane Mazeau, Evelyne Zanghellini, Francette Ettore, Patricia Formento, Pierre Chauvel, Claude-Michel Lalanne, Adel Courdi, Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. European Journal of Cancer and Clinical Oncology. ,vol. 24, pp. 1445- 1455 ,(1988) , 10.1016/0277-5379(88)90335-5
Cyril Ronco, Geoffroy Sorin, Florian Nachon, Richard Foucault, Ludovic Jean, Anthony Romieu, Pierre-Yves Renard, Synthesis and structure–activity relationship of Huprine derivatives as human acetylcholinesterase inhibitors Bioorganic & Medicinal Chemistry. ,vol. 17, pp. 4523- 4536 ,(2009) , 10.1016/J.BMC.2009.05.005